ENANTA PHARMACEUTICALS INC 4
4 · ENANTA PHARMACEUTICALS INC · Filed Feb 12, 2016
Insider Transaction Report
Form 4
AFTING ERNST-GUNTER
Director
Transactions
- Award
Stock Option (right to buy)
2016-02-11+6,000→ 6,000 totalExercise: $25.58Exp: 2026-02-11→ Common Stock (6,000 underlying)
Footnotes (1)
- [F1]Such option will become exercisable monthly in substantially equal installments over one year, beginning from the date of grant (February 11, 2016), with the final monthly installment vesting at the 2017 annual meeting of stockholders.